<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34074767</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>23</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>ALS-linked PFN1 variants exhibit loss and gain of functions in the context of formin-induced actin polymerization.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2024605118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2024605118</ELocationID><Abstract><AbstractText>Profilin-1 (PFN1) plays important roles in modulating actin dynamics through binding both monomeric actin and proteins enriched with polyproline motifs. Mutations in PFN1 have been linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS). However, whether ALS-linked mutations affect PFN1 function has remained unclear. To address this question, we employed an unbiased proteomics analysis in mammalian cells to identify proteins that differentially interact with mutant and wild-type (WT) PFN1. These studies uncovered differential binding between two ALS-linked PFN1 variants, G118V and M114T, and select formin proteins. Furthermore, both variants augmented formin-mediated actin assembly relative to PFN1 WT. Molecular dynamics simulations revealed mutation-induced changes in the internal dynamic couplings within an alpha helix of PFN1 that directly contacts both actin and polyproline, as well as structural fluctuations within the actin- and polyproline-binding regions of PFN1. These data indicate that ALS-PFN1 variants have the potential for heightened flexibility in the context of the ternary actin-PFN1-polyproline complex during actin assembly. Conversely, PFN1 C71G was more severely destabilized than the other PFN1 variants, resulting in reduced protein expression in both transfected and ALS patient lymphoblast cell lines. Moreover, this variant exhibited loss-of-function phenotypes in the context of actin assembly. Perturbations in actin dynamics and assembly can therefore result from ALS-linked mutations in PFN1. However, ALS-PFN1 variants may dysregulate actin polymerization through different mechanisms that depend upon the solubility and stability of the mutant protein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0001-7441-9806</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funes</LastName><ForeName>Salome</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKeon</LastName><ForeName>Jeanne E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Brittany R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0003-4779-1375</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boopathy</LastName><ForeName>Sivakumar</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0524-3338</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Lauren C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilsel</LastName><ForeName>Osman</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0342-3207</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xe9;gou</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0356-3127</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Paris, CNRS, Institut Jacques Monod, F-75006 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosco</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-3735-3729</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605; daryl.bosco@umassmed.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM137529</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM139316</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS090352</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000199">Actins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000080865">Formins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495738">PFN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051304">Profilins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000199" MajorTopicYN="N">Actins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080865" MajorTopicYN="N">Formins</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058105" MajorTopicYN="Y">Polymerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051304" MajorTopicYN="N">Profilins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072756" MajorTopicYN="N">Protein Conformation, alpha-Helical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057165" MajorTopicYN="N">Proteostasis Deficiencies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">actin dynamics</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">formins</Keyword><Keyword MajorTopicYN="N">profilin-1</Keyword><Keyword MajorTopicYN="N">protein misfolding</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34074767</ArticleId><ArticleId IdType="pmc">PMC8201830</ArticleId><ArticleId IdType="doi">10.1073/pnas.2024605118</ArticleId><ArticleId IdType="pii">2024605118</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R. H., Al-Chalabi A., Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162&#x2013;172 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti M., et al. ., Phenotypic suppression of ALS/FTD-associated neurodegeneration highlights mechanisms of dysfunction. J. Neurosci. 39, 8217&#x2013;8224 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794934</ArticleId><ArticleId IdType="pubmed">31619490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. H., et al. ., Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488, 499&#x2013;503 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B. N., et al. ., Novel mutations support a role for profilin 1 in the pathogenesis of ALS. Neurobiol. Aging 36, 1602.e17&#x2013;27 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4357530</ArticleId><ArticleId IdType="pubmed">25499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., et al. ., PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis. Neurobiol. Aging 34, 1922.e1&#x2013;5 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23428184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., et al. ., A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging 34, 1708.e1&#x2013;6 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6591725</ArticleId><ArticleId IdType="pubmed">23141414</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K., Pasterkamp R. J., Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 137, 859&#x2013;877 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G. A., et al. ., Axonal transport defects in neurodegenerative diseases. J. Neurosci. 29, 12776&#x2013;12786 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801051</ArticleId><ArticleId IdType="pubmed">19828789</ArticleId></ArticleIdList></Reference><Reference><Citation>Boopathy S., et al. ., Structural basis for mutation-induced destabilization of profilin 1 in ALS. Proc. Natl. Acad. Sci. U.S.A. 112, 7984&#x2013;7989 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491777</ArticleId><ArticleId IdType="pubmed">26056300</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Poggetto E., Bemporad F., Tatini F., Chiti F., Mutations of profilin-1 associated with amyotrophic lateral sclerosis promote aggregation due to structural changes of its native state. ACS Chem. Biol. 10, 2553&#x2013;2563 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26226631</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Poggetto E., et al. ., Stability of an aggregation-prone partially folded state of human profilin-1 correlates with aggregation propensity. J. Biol. Chem. 293, 10303&#x2013;10313 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028969</ArticleId><ArticleId IdType="pubmed">29760185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekouei M., et al. ., Changes in biophysical characteristics of PFN1 due to mutation causing amyotrophic lateral sclerosis. Metab. Brain Dis. 33, 1975&#x2013;1984 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6230493</ArticleId><ArticleId IdType="pubmed">30203378</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M. D., Bieri G., Kolaitis R. M., Taylor J. P., Gitler A. D., Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J. Neurosci. 34, 8083&#x2013;8097 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4051967</ArticleId><ArticleId IdType="pubmed">24920614</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard T. D., Actin and actin-binding proteins. Cold Spring Harb. Perspect. Biol. 8, a018226 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968159</ArticleId><ArticleId IdType="pubmed">26988969</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W., The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 14, 461&#x2013;469 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15308213</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhard M., et al. ., The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J. 14, 1583&#x2013;1589 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC398250</ArticleId><ArticleId IdType="pubmed">7737110</ArticleId></ArticleIdList></Reference><Reference><Citation>Campellone K. G., Welch M. D., A nucleator arms race: Cellular control of actin assembly. Nat. Rev. Mol. Cell Biol. 11, 237&#x2013;251 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929822</ArticleId><ArticleId IdType="pubmed">20237478</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtemanche N., Mechanisms of formin-mediated actin assembly and dynamics. Biophys. Rev. 10, 1553&#x2013;1569 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6297096</ArticleId><ArticleId IdType="pubmed">30392063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann D., Kovar D. R., Feeling the force: Formin&#x2019;s role in mechanotransduction. Curr. Opin. Cell Biol. 56, 130&#x2013;140 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30639952</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkam D., Feldman E. Z., Singh A., Kiaei M., Profilin1 biology and its mutation, actin(g) in disease. Cell. Mol. Life Sci. 74, 967&#x2013;981 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5311022</ArticleId><ArticleId IdType="pubmed">27669692</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt E. J., Bosco D. A., IP-MS of ALS-linked PFN1 variants. Proteomics Identifications database. https://www.ebi.ac.uk/pride/archive/projects/PXD015602. Deposited 26 September 2019.</Citation></Reference><Reference><Citation>Choi H., et al. ., SAINT: Probabilistic scoring of affinity purification-mass spectrometry data. Nat. Methods 8, 70&#x2013;73 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3064265</ArticleId><ArticleId IdType="pubmed">21131968</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., et al. ., STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447&#x2013;D452 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383874</ArticleId><ArticleId IdType="pubmed">25352553</ArticleId></ArticleIdList></Reference><Reference><Citation>Thul P. J., et al. ., A subcellular map of the human proteome. Science 356, eaal3321 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28495876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L., et al. ., Modulation of formin processivity by profilin and mechanical tension. eLife 7, e34176 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969902</ArticleId><ArticleId IdType="pubmed">29799413</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;gou A., Carlier M. F., Romet-Lemonne G., Formin mDia1 senses and generates mechanical forces on actin filaments. Nat. Commun. 4, 1883 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23695677</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyners C., Mertens M., Wessig P., Meyer-Almes F. J., A fluorescence-lifetime-based binding assay for class IIa histone deacetylases. Chemistry 23, 3107&#x2013;3116 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27922200</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezin M. Y., Achilefu S., Fluorescence lifetime measurements and biological imaging. Chem. Rev. 110, 2641&#x2013;2684 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924670</ArticleId><ArticleId IdType="pubmed">20356094</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz H., Hill coefficients, dose-response curves and allosteric mechanisms. J. Chem. Biol. 3, 37&#x2013;44 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2816740</ArticleId><ArticleId IdType="pubmed">19779939</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella E. C., Machesky L. M., Kaiser D. A., Pollard T. D., Structural requirements and thermodynamics of the interaction of proline peptides with profilin. Biochemistry 35, 16535&#x2013;16543 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8987987</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidt E. M., Scott B. J., Kovar D. R., Formin differentially utilizes profilin isoforms to rapidly assemble actin filaments. J. Biol. Chem. 284, 673&#x2013;684 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18978356</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;gou A., et al. ., Individual actin filaments in a microfluidic flow reveal the mechanism of ATP hydrolysis and give insight into the properties of profilin. PLoS Biol. 9, e1001161 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181223</ArticleId><ArticleId IdType="pubmed">21980262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovar D. R., Harris E. S., Mahaffy R., Higgs H. N., Pollard T. D., Control of the assembly of ATP- and ADP-actin by formins and profilin. Cell 124, 423&#x2013;435 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16439214</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavylonis D., Kovar D. R., O&#x2019;Shaughnessy B., Pollard T. D., Model of formin-associated actin filament elongation. Mol. Cell 21, 455&#x2013;466 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3716371</ArticleId><ArticleId IdType="pubmed">16483928</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul A. S., Pollard T. D., The role of the FH1 domain and profilin in formin-mediated actin-filament elongation and nucleation. Curr. Biol. 18, 9&#x2013;19 (2008).Corrected in: Curr. Biol. 18, 233 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712528</ArticleId><ArticleId IdType="pubmed">18160294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash L. L., et al. ., Small-molecule intramimics of formin autoinhibition: A new strategy to target the cytoskeletal remodeling machinery in cancer cells. Cancer Res. 73, 6793&#x2013;6803 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24242070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tojkander S., Gateva G., Lappalainen P., Actin stress fibers&#x2013;Assembly, dynamics and biological roles. J. Cell Sci. 125, 1855&#x2013;1864 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22544950</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe N., Kato T., Fujita A., Ishizaki T., Narumiya S., Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat. Cell Biol. 1, 136&#x2013;143 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10559899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotty J. D., et al. ., Profilin-1 serves as a gatekeeper for actin assembly by Arp2/3-dependent and -independent pathways. Dev. Cell 32, 54&#x2013;67 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296256</ArticleId><ArticleId IdType="pubmed">25543281</ArticleId></ArticleIdList></Reference><Reference><Citation>Girvan M., Newman M. E., Community structure in social and biological networks. Proc. Natl. Acad. Sci. U.S.A. 99, 7821&#x2013;7826 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122977</ArticleId><ArticleId IdType="pubmed">12060727</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X. Q., et al. ., Dynamic coupling and allosteric networks in the &#x3b1; subunit of heterotrimeric G proteins. J. Biol. Chem. 291, 4742&#x2013;4753 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4813496</ArticleId><ArticleId IdType="pubmed">26703464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferron F., Rebowski G., Lee S. H., Dominguez R., Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena/VASP. EMBO J. 26, 4597&#x2013;4606 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063483</ArticleId><ArticleId IdType="pubmed">17914456</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C., Dikic I., Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366, 818&#x2013;822 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtemanche N., Pollard T. D., Determinants of formin homology 1 (FH1) domain function in actin filament elongation by formins. J. Biol. Chem. 287, 7812&#x2013;7820 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3293521</ArticleId><ArticleId IdType="pubmed">22247555</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk J., et al. ., Profilin and formin constitute a pacemaker system for robust actin filament growth. eLife 8, e50963 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6867828</ArticleId><ArticleId IdType="pubmed">31647411</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D., et al. ., Mutant profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum. Mol. Genet. 26, 686&#x2013;701 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968635</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., et al. ., Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proc. Natl. Acad. Sci. U.S.A. 113, E6209&#x2013;E6218 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068285</ArticleId><ArticleId IdType="pubmed">27681617</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez C., et al. ., Profilin regulates F-actin network homeostasis by favoring formin over Arp2/3 complex. Dev. Cell 32, 43&#x2013;53 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4293355</ArticleId><ArticleId IdType="pubmed">25543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kweon J. H., Kim S., Lee S. B., The cellular basis of dendrite pathology in neurodegenerative diseases. BMB Rep. 50, 5&#x2013;11 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5319658</ArticleId><ArticleId IdType="pubmed">27502014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin A. M. G., Shadfar S., Vidal M., Jamali M. S., Atkin J. D., Motor neuron susceptibility in ALS/FTD. Front. Neurosci. 13, 532 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., et al. ., An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929&#x2013;11947 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Colucci-Guyon E., et al. ., A role for mammalian diaphanous-related formins in complement receptor (CR3)-mediated phagocytosis in macrophages. Curr. Biol. 15, 2007&#x2013;2012 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16303559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D. W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761&#x2013;772 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron D. M., et al. ., Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS. Hum. Mol. Genet. 28, 2143&#x2013;2160 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6586143</ArticleId><ArticleId IdType="pubmed">30806671</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>